Market Place
Sourcing Support
All News #Library
Rare Diseases
Sentynl Therapeutics Enters into Agreement with PRG S&T
16 Mar 2026 //
PR NEWSWIRE
Fortress Unit Cyprium Sells Rare Pediatric PRV For $205M
23 Feb 2026 //
GLOBENEWSWIRE
Sentynl Therapeutics Inc. Announces FDA Approval of ZYCUBO
12 Jan 2026 //
PRESS RELEASE
Sentynl Therapeutics Announces FDA Acceptance Of CUTX-101 NDA
15 Dec 2025 //
PR NEWSWIRE
Sentynl Selects Mytomorrows To Lead Managed Access Program
10 Dec 2025 //
PR NEWSWIRE
Fortress Bio, Cyprium Therapeutics Update NDA For CUTX-101
01 Oct 2025 //
GLOBENEWSWIRE
Er-Kim, Sentynl Therapeutics Partner On Nulibry & Zokinvy
24 Sep 2025 //
GLOBENEWSWIRE
Sentynl Acquires Zokinvy® For Progeria From Eiger Globally
03 May 2024 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.